Abstract CT139: Phase I study of GDC-0425, a checkpoint kinase 1 inhibitor, in combination with gemcitabine in patients with refractory solid tumors
Jeffrey R. Infante,Antoine Hollebecque,Sophie Postel-Vinay,Todd Bauer, Beth Blackwood,Marie Evangelista,Sami Mahrus,Frank Peale,Xuyang Lu,Srikumar Sahasranaman,Rui Zhu,Yuan Chen,Xiao Ding,Elaine Murray,Jennifer Schutzman,Jennifer Lauchle,Jean-Charles Soria,Patricia LoRusso Clinical Trials（2015）
AI 理解论文
溯源树
样例
